無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の血小板および血漿市場:市場規模、潜在成長性、価格動向、競合情勢、市場シェア、予測

Platelet and Plasma Market Size By Component, By Application, By Distribution Channel Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024

発行 Global Market Insights Inc. 商品コード 671948
出版日 ページ情報 英文 120 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
世界の血小板および血漿市場:市場規模、潜在成長性、価格動向、競合情勢、市場シェア、予測 Platelet and Plasma Market Size By Component, By Application, By Distribution Channel Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024
出版日: 2018年07月12日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界の血小板および血漿市場について調査し、市場の概要、構成要素・応用領域・流通経路・地域別の市場動向、市場規模の推移と予測(過去5年間・今後7年間分)、市場シェア、市場成長への影響要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査手法と範囲

  • 調査手法
  • 市場定義
  • 予測パラメーター
  • 情報源

第2章 エグゼクティブサマリー

  • 全方位的産業分析:セグメント別

第3章 産業考察

  • イントロダクション
  • 産業区分
  • 産業環境
  • 産業エコシステムの分析
  • 産業影響要因
    • 成長要因
    • 阻害要因・課題
  • 潜在成長性の分析
  • 価格分析
  • ファイブフォース分析
  • PESTEL分析

第4章 血小板および血漿市場:構成要素別

  • 市場動向:構成要素別
  • 血小板
  • 血漿

第5章 血小板および血漿市場:応用領域別

  • 市場動向:応用領域別
  • 血友病
  • 血小板減少症
  • 術中
  • 血小板機能異常症
  • 凝固因子欠乏症候群
  • 血栓性血小板減少性紫斑病(TTP)
  • 出血
  • 肝疾患
  • その他の血小板疾患
  • その他の血漿疾患

第6章 血小板および血漿市場:流通経路別

  • 市場動向:流通経路別
  • 病院
  • 外来外科センター
  • その他

第7章 血小板および血漿市場:地域別

  • 市場シェア:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • America's Blood Centers
  • American Red Cross
  • American Association of Blood Banks
  • Blood Centers of America
  • Brazilian Red Cross
  • Canadian Red Cross
  • European Blood Alliance
  • French Red Cross
  • German Red Cross
  • Indian Red Cross
  • Italian Red Cross
  • Japanese Red Cross
  • Red Cross Society of China
  • Saudi Red Crescent Authority
  • South African Red Cross Society
  • Spanish Red Cross

表リスト

図表

Data Tables

  • TABLE 1: Platelet and plasma industry 360 degree synopsis, 2013 - 2024
  • TABLE 2: Global platelet and plasma market, 2013 - 2024 (USD Million)
  • TABLE 3: Global platelet and plasma market, by component, 2013 - 2024 (USD Million)
  • TABLE 4: Global platelet and plasma market, by application, 2013 - 2024 (USD Million)
  • TABLE 5: Global platelet and plasma market, by region, 2013 - 2024 (USD Million)
  • TABLE 6: Industry impact forces
  • TABLE 7: Platelets market, by region, 2013 - 2024 (USD Million)
  • TABLE 8: Plasma market, by region, 2013 - 2024 (USD Million)
  • TABLE 9: Hemophilia market, by region, 2013 - 2024 (USD Million)
  • TABLE 10: Thrombocytopenia market, by region, 2013 - 2024 (USD Million)
  • TABLE 11: Perioperative indications market, by region, 2013 - 2024 (USD Million)
  • TABLE 12: Platelet function disorders market, by region, 2013 - 2024 (USD Million)
  • TABLE 13: Other platelet applications market, by region, 2013 - 2024 (USD Million)
  • TABLE 14: Coagulation factor deficiencies market, by region, 2013 - 2024 (USD Million)
  • TABLE 15: Thrombotic thrombocytopenic purpura market, by region, 2013 - 2024 (USD Million)
  • TABLE 16: Hemorrhage market, by region, 2013 - 2024 (USD Million)
  • TABLE 17: Liver disease market, by region, 2013 - 2024 (USD Million)
  • TABLE 18: Other plasma applications market by region, 2013 - 2024 (USD Million)
  • TABLE 19: Hospitals market, by region, 2013 - 2024 (USD Million)
  • TABLE 20: Ambulatory surgical centers market, by region, 2013 - 2024 (USD Million)
  • TABLE 21: Others market, by region, 2013 - 2024 (USD Million)
  • TABLE 22: North America platelet and plasma market size, by country, 2013 - 2024 (USD Million)
  • TABLE 23: North America platelet and plasma market size, by country, 2013 - 2024 (USD Million)
  • TABLE 24: North America platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 25: North America platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 26: North America platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 27: U.S. platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 28: U.S. platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 29: U.S. platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 30: Canada platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 31: Canada platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 32: Canada platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 33: Europe platelet and plasma market size, by country, 2013 - 2024 (USD Million)
  • TABLE 34: Europe platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 35: Europe platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 36: Europe platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 37: Germany platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 38: Germany platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 39: Germany platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 40: UK platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 41: UK platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 42: UK platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 43: France platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 44: France platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 45: France platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 46: Italy platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 47: Italy platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 48: Italy platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 49: Spain platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 50: Spain platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 51: Spain platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 52: Asia Pacific platelet and plasma market size, by country, 2013 - 2024 (USD Million)
  • TABLE 53: Asia Pacific platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 54: Asia Pacific platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 55: Asia Pacific platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 56: Japan platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 57: Japan platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 58: Japan platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 59: China platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 60: China platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 61: China platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 62: India platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 63: India platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 64: India platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 65: Latin America platelet and plasma market size, by country, 2013 - 2024 (USD Million)
  • TABLE 66: Latin America platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 67: Latin America platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 68: Latin America platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 69: Brazil platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 70: Brazil platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 71: Brazil platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 72: Mexico platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 73: Mexico platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 74: Mexico platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 75: MEA platelet and plasma market size, by country, 2013 - 2024 (USD Million)
  • TABLE 76: MEA platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 77: MEA platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 78: MEA platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 79: South Africa platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 80: South Africa platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 81: South Africa platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)
  • TABLE 82: Saudi Arabia platelet and plasma market size, by component, 2013 - 2024 (USD Million)
  • TABLE 83: Saudi Arabia platelet and plasma market size, by application, 2013 - 2024 (USD Million)
  • TABLE 84: Saudi Arabia platelet and plasma market size, by distribution channel, 2013 - 2024 (USD Million)

Charts & Figures

  • FIG. 1: Industry segmentation
  • FIG. 2: Global platelet and plasma market, 2013 - 2024 (USD Billion)
  • FIG. 3: Growth potential analysis, by component
  • FIG. 4: Growth potential analysis, by application
  • FIG. 5: Growth potential analysis, by distribution channel
  • FIG. 6: Porter's analysis
  • FIG. 7: PESTEL Analysis
目次
Product Code: 2737

Title:
Platelet and Plasma Market Size By Component (Platelets, Plasma), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Coagulation Factor Deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver Disease), By Distribution Channel (Hospitals, Ambulatory Surgical Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, India, China, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2018 - 2024.

Platelets And Plasma Market will exceed USD 6.5 billion by 2024; as per a new research report.

Increasing number of blood transfusion in regions such as Europe will drive the growth of platelets and plasma market over the forecast period. Millions of people receive donated blood and its components each year. As per the statistics of the European commission over 20 million units of blood or blood components were transfused in 2017. Many developed countries provide a mixed system of compensated as well non-compensated blood donation. Moreover, various government initiatives to encourage blood donation among people will further accelerate the market growth during the forthcoming years.

Growing incidences of rare and infectious diseases such as hepatitis, hemophilia, thrombotic thrombocytopenic purpura will serve to be another impact rendering factor in the growth of platelets and plasma market. Around 3.2 million people in the U.S. are affected by Hepatitis C ultimately leading to hepatocellular carcinoma. Use of platelets and plasma in treatment of hepatocellular carcinoma and other liver diseases will fuel the demand for platelets and plasma. However, lack of treatment affordability in developing countries such as India, China, Brazil and Mexico as well as stringent regulations imposed on plasma collection will restrain the industry growth to some extent throughout the analysis period.

Platelet segment is expected to generate highest revenue of around USD 4.5 billion in 2024, owing to the rising number of surgeries being performed coupled with increasing demand for minimally invasive procedures worldwide. Demand for platelets and its analogs is increasing in recent years owing to its varied prophylactic and therapeutic benefits. Growing incidences of chronic and rare diseases worldwide will further augment the market growth during the forecast period. Furthermore, rising disposable income leading to increasing affordability, developments in healthcare infrastructure as well as growing adoption of advanced technologies will accelerate the growth of platelets and plasma market in the coming years.

Thrombocytopenia segment will grow at a robust CAGR of around 2.9% over the foreseeable period attributable to the growing number of thrombocytopenia cases worldwide. Thrombocytopenia is characterized by reduced platelet count owing to number of factors such as chemotherapy drugs, heavy alcohol consumption and leukemia. According to the Journal of Hepatology, thrombocytopenia is commonly found in around 76% patients suffering from chronic liver diseases. Rising prevalence of rare infectious diseases coupled with growing elderly population base will fuel the demand for platelets and plasma over the forecast period.

Hospitals segment dominated the market in 2017 with a revenue share of around 62.5% and is estimated to show remarkable growth in the coming years. Rising number of hospitalizations owing to prevalence of chronic diseases such as hepatitis C, hemophilia and other rare diseases will drive the platelets and plasma market growth during the analysis period. Availability of advanced healthcare facilities, growing elderly patient base as well as reimbursement policies for hospital treatments will upsurge the size of platelets and plasma market during the analysis timeframe.

U.S. platelets and plasma market accounted for the highest revenue of USD 2 billion in 2017 owing to the rising incidences of chronic diseases coupled with increasing geriatric population base will augment the market growth. For instance, plasma is used in the treatment of neurological disorders such as multiple sclerosis, inflammatory dysimmune neuropathies and myasthenia gravis. High adoption of technological advancements as well as availability of advanced healthcare facilities will drive the market growth. Moreover, increased smoking, lifestyle changes and other environmental factors will further boost the demand for platelets and plasma during the forthcoming years.

Some of the notable industry players of global platelets and plasma market are: America's Blood Centers, American Red Cross, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Spanish Red Cross, Saudi Red Crescent Authority and South Africa Red Cross Society. Industry players are primarily focusing on developing novel technologies to diversify the product applications for treatment of various diseases. They are also emphasizing on mergers, partnerships and collaborations to encourage blood donation and use of blood components in disease treatments.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
    • 1.4.1.1. Paid sources
    • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Platelet and plasma industry 360º synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Component trends
    • 2.1.3. Application trends
    • 2.1.4. Distribution channel trends
    • 2.1.5. Regional trends

Chapter 3. Platelet And Plasma Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry ecosystem
    • 3.3.1. Value chain analysis
    • 3.3.2. Distribution channel analysis
  • 3.4. Industry impact forces
    • 3.4.1. Growth drivers
    • 3.4.1.1. Higher number of blood transfusions in Europe
    • 3.4.1.2. Recent advances in therapeutic protein drug development
    • 3.4.1.3. Increasing prevalence of liver diseases in elderly population globally
    • 3.4.1.4. Exclusive use of plasma for treatment of rare diseases in Europe
    • 3.4.1.5. Fair reimbursement in developed countries
    • 3.4.2. Industry pitfalls & challenges
    • 3.4.2.1. Stringent regulatory policies
    • 3.4.2.2. Affordability issue in APAC and Latin America due to high costs
  • 3.5. Growth potential analysis
    • 3.5.1. By component
    • 3.5.2. By application
    • 3.5.3. By distribution channel
  • 3.6. Pricing analysis, 2017
    • 3.6.1. Platelets
    • 3.6.2. Plasma
  • 3.7. Porter's analysis
  • 3.8. PESTEL analysis

Chapter 4. Platelet And Plasma Market, By Component

  • 4.1. Key segment trends
  • 4.2. Platelets
    • 4.2.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.3. Plasma
    • 4.3.1. Market size, by region, 2013 - 2024 (USD Million)

Chapter 5. Platelet And Plasma Market, By Application

  • 5.1. Key segment trends
  • 5.2. Hemophilia
    • 5.2.1. Market size, by region, 2013-2024 (USD Million)
  • 5.3. Thrombocytopenia
    • 5.3.1. Market size, by region, 2013-2024 (USD Million)
  • 5.4. Perioperative indications
    • 5.4.1. Market size, by region, 2013-2024 (USD Million)
  • 5.5. Platelet function disorders
    • 5.5.1. Market size, by region, 2013-2024 (USD Million)
  • 5.6. Other platelet applications
    • 5.6.1. Market size, by region, 2013-2024 (USD Million)
  • 5.7. Coagulation factor deficiencies
    • 5.7.1. Market size, by region, 2013-2024 (USD Million)
  • 5.8. Thrombotic thrombocytopenic purpura
    • 5.8.1. Market size, by region, 2013-2024 (USD Million)
  • 5.9. Hemorrhage
    • 5.9.1. Market size, by region, 2013-2024 (USD Million)
  • 5.10. Liver disease
    • 5.10.1. Market size, by region, 2013-2024 (USD Million)
  • 5.11. Other plasma applications
    • 5.11.1. Market size, by region, 2013-2024 (USD Million)

Chapter 6. Platelet And Plasma Market, By Distribution Channel

  • 6.1. Key segment trends
  • 6.2. Hospitals
    • 6.2.1. Market size, by region, 2013 - 2024 (USD Million)
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Market size, by region, 2013 - 2024 (USD Million)
  • 6.4. Others
    • 6.4.1. Market size, by region, 2013 - 2024 (USD Million)

Chapter 7. Platelet And Plasma Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.2.2. Market size, by component, 2013 - 2024 (USD Million)
    • 7.2.3. Market size, by application, 2013 - 2024 (USD Million)
    • 7.2.4. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.2.5. U.S.
    • 7.2.5.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.2.5.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.2.5.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.2.6. Canada
    • 7.2.6.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.2.6.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.2.6.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.3.2. Market size, by component, 2013 - 2024 (USD Million)
    • 7.3.3. Market size, by application, 2013 - 2024 (USD Million)
    • 7.3.4. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.3.5. Germany
    • 7.3.5.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.3.5.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.3.5.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.3.6. UK
    • 7.3.6.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.3.6.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.3.6.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.3.7. France
    • 7.3.7.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.3.7.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.3.7.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.3.8. Italy
    • 7.3.8.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.3.8.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.3.8.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.3.9. Spain
    • 7.3.9.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.3.9.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.3.9.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.4.2. Market size, by component, 2013 - 2024 (USD Million)
    • 7.4.3. Market size, by application, 2013 - 2024 (USD Million)
    • 7.4.4. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.4.5. Japan
    • 7.4.5.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.4.5.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.4.5.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.4.6. China
    • 7.4.6.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.4.6.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.4.6.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.4.7. India
    • 7.4.7.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.4.7.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.4.7.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.5.2. Market size, by component, 2013 - 2024 (USD Million)
    • 7.5.3. Market size, by application, 2013 - 2024 (USD Million)
    • 7.5.4. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.5.5. Brazil
    • 7.5.5.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.5.5.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.5.5.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.5.6. Mexico
    • 7.5.6.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.5.6.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.5.6.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Market size, by country, 2013 - 2024 (USD Million)
    • 7.6.2. Market size, by component, 2013 - 2024 (USD Million)
    • 7.6.3. Market size, by application, 2013 - 2024 (USD Million)
    • 7.6.4. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.6.5. South Africa
    • 7.6.5.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.6.5.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.6.5.3. Market size, by distribution channel, 2013 - 2024 (USD Million)
    • 7.6.6. Saudi Arabia
    • 7.6.6.1. Market size, by component, 2013 - 2024 (USD Million)
    • 7.6.6.2. Market size, by application, 2013 - 2024 (USD Million)
    • 7.6.6.3. Market size, by distribution channel, 2013 - 2024 (USD Million)

Chapter 8. Company Profiles

  • 8.1. America's Blood Centers
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. American Red Cross
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. American Association of Blood Banks
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Blood Centers of America
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Brazilian Red Cross
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Canadian Red Cross
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. European Blood Alliance
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. French Red Cross
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. German Red Cross
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Indian Red Cross
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. Italian Red Cross
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Japanese Red Cross
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Red Cross Society of China
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
  • 8.14. Saudi Red Crescent Authority
    • 8.14.1. Business overview
    • 8.14.2. Financial data
    • 8.14.3. Product landscape
    • 8.14.4. Strategic outlook
    • 8.14.5. SWOT analysis
  • 8.15. South African Red Cross Society
    • 8.15.1. Business overview
    • 8.15.2. Financial data
    • 8.15.3. Product landscape
    • 8.15.4. Strategic outlook
    • 8.15.5. SWOT analysis
  • 8.16. Spanish Red Cross
    • 8.16.1. Business overview
    • 8.16.2. Financial data
    • 8.16.3. Product landscape
    • 8.16.4. Strategic outlook
    • 8.16.5. SWOT analysis
Back to Top